Skip Navigation

University Bulletin: Undergraduate Programs 2003-2004 The George Washington University  

 
    
 
UNIVERSITY BULLETIN » GRADUATE PROGRAMS »

MOLECULAR MEDICINE

 

B. Bouscarel (Director), M. Batshaw, M. Bell, P. Berg, S. Ceryak, V.A. Chiappinelli, A. Chiaramello, E.C. DeFabo, S. Dopkins, S.W. Fu, V. Gallo, A.L. Goldstein, Y. Hathout, R. Hawley, T. Haydar, E. Hoffman, V. Hu, F. Kashanchi, K.A. Kennedy, E. Kirkness, J.M. Krum, A. Kumar, S. Ladisch, P. Latham, N. Lee, C.W. Linebaugh, T. McDonald, H.G. Mandel, T. McCaffrey, D. Mendelowitz, S.A. Moody, T.W. Moody, J. Neiderhiser, F.P. Noonan, T. O'Brien, R.K. Packer, S.R. Patierno, D.C. Perry, K.D. Peusner, J. Philbeck, D. Reiss, M. Rojkind, M.C. Rose, J.M. Rosenstein, L.A. Rothblat, N. Sarvazyan, E.M. Sorenson, M.A. Stepp, Y. Su, L.L. Werling

Doctor of Philosophy in the field of molecular medicine—Prerequisite: A bachelor’s degree in chemistry, biological sciences, or an approved related field.

Required: the general requirements stated under Columbian College of Arts and Sciences. Course work must include the biomedical sciences core curriculum, with MMed 213, 214, and one of the following: Anat/Idis 212, Phar 205, or MMed 221. Pertinent electives include MMed 280, 222, Bioc 250; BiSc 249, 274, 275; Psyc 268 or 281.

Research fields: neuroscience—neural transplantation, molecular mechanisms of action of drugs of abuse, neurotransmitter systems, developmental neurobiology, psychobiology of learning and memory, function of ion channels, receptors, and transporters; oncology—cancer chemotherapy and mechanisms of resistance, UV light, tumor cell biology and metabolism, gene regulation, oncogenes and tumor suppressor genes, growth factors, chemotherapy and mechanisms of resistance, immunotherapy, development of immunological and molecular markers for diagnosis and detection, tumor immunology, epidemiology and prevention, cancer and AIDS, mechanisms of metastasis, transgenic models of cancer; pharmacology—molecular carcinogenesis, genetic toxicology, cancer chemotherapy, neuropharmacology, biochemical and molecular pharmacology and toxicology.

213 Molecular Medicine I (3)  
  Physiological bases of major organ systems and origins of disease. Prerequisite: BmSc 210, 211, 212.
214 Molecular Medicine II (2)  
  Research topics in molecular medicine, including cellular and behavioral neuroscience, pharmacology, physiology, and pathophysiology. May be repeated for credit. Prerequisite: MMed 213 and consent of instructor.
221 The Basic Science of Oncology (3)  
  Epidemiology, genetics, viruses, oncogenes, chemical carcinogenesis, radiation carcinogenesis, tumor growth, metastasis, biochemistry of cancer cells, tumor markers, hormones and cancer, cancer immunobiology, radiotherapy, chemotherapy and immunotherapy. (Fall)
222 Molecular Oncology (2)  
  Seminar course dealing with molecular basis for the topics introduced in MMed 221. (Spring)
280 Neurophysiology and Neuropharmacology (3)  
  Basic principles of electrophysiology and electrophysiological techniques. Basic principles of neuropharmacology, including neurobiological basis for mental health and disease. (Spring)
398 Advanced Reading and Research (arr.)  
  Limited to students preparing for the Doctor of Philosophy general examination. May be repeated for credit.
399 Dissertation Research (arr.)  
  Limited to Doctor of Philosophy candidates. May be repeated for credit.
 

The George Washington University

© 2009 University Bulletin
The George Washington University All rights reserved.

Information in this bulletin is generally accurate as of fall 2008. The University reserves the right to change courses, programs, fees, and the academic calendar, or to make other changes deemed necessary or desirable, giving advance notice of change when possible.